Research Radar archive
What the system was watching on July 15, 2026
Frozen snapshot — captured at . This page does not refresh. Live view: today's Radar.
AI stock ideas
AI stock ideas
Short-term ideas with entry date, tracking window, and public outcome.
DatedTrackedOutcome visibleResearch only
| Ticker | Catalyst | Window | Status | Link |
|---|---|---|---|---|
PYPL PayPal Holdings, Inc. Financial Services | Selected for strong near-term momentum and a fresh catalyst: shares rose about 26% over 21 trading days, including a sharp 2026-07-15 spike after reports that Stripe and Advent made a buyout proposal above $53B; valuation also remains low at roughly 7x-8x earnings. | Jul 15–22 | Active (as of archive) | Open |
BLLN BillionToOne, Inc. Healthcare | Strong breakout profile: stock rose about 24.5% over 21 trading days and made a fresh high on 2026-07-15. Supports include raised 2026 guidance, strong Q1 revenue growth, positive free cash flow, and a peer-reviewed Northstar Response study supporting the clinical story. | Jul 15–22 | Active (as of archive) | Open |
AORT Artivion, Inc. Healthcare | Near-term catalyst story with concrete regulatory news: FDA approval of AMDS on 2026-06-29 and completed Endospan acquisition on 2026-05-18 support launch momentum. Q1 revenue rose 18% YoY and adjusted EBITDA rose 26%, while the stock is up about 15% over 21 trading days. | Jul 15–22 | Active (as of archive) | Open |
FA First Advantage Corporation Industrials | Momentum and index-inclusion setup: stock rose about 27% over 21 trading days and hit a fresh short-term high. Q1 2026 was a record quarter, management reaffirmed full-year guidance, repurchased shares, prepaid debt, and S&P SmallCap 600 inclusion adds trading support. | Jul 15–22 | Active (as of archive) | Open |
PGNY Progyny, Inc. Healthcare | Strong healthcare momentum with solid fundamentals: shares rose 20.5% over 21 trading days and hit a 52-week high on 2026-07-14. Record Q1 revenue of $328.5M, strong selling-season demand, a $200M buyback authorization, and a Zacks Rank #1 support near-term research interest. | Jul 15–22 | Active (as of archive) | Open |
CHYM Chime Financial, Inc. Class A Common Stock Financial Services | Fintech momentum candidate: stock rose 27.7% over 21 trading days and printed a new short-term high on 2026-07-15. Q1 2026 revenue beat guidance, the company reached first GAAP profitability as a public company, generated positive FCF, and analyst commentary cited about 71.5% implied upside. | Jul 15–22 | Active (as of archive) | Open |
BZH Beazer Homes USA, Inc. Consumer Cyclical | Deal-driven short-term catalyst: Dream Finders raised its bid to $32 per share, Beazer indicated interest from other parties, and a major shareholder is pushing engagement. Shares are up about 21% over 21 trading days to a new window high, supporting M&A-driven continuation potential. | Jul 15–22 | Active (as of archive) | Open |
HRB H&R Block, Inc. Consumer Cyclical | Beat-and-raise momentum name: latest earnings showed revenue up 5.3%, adjusted EPS up 11.9%, and FY2026 guidance raised. Shares rose about 14.6% over 21 trading days to a new 21-day high, with additional support from favorable headlines, AI Tax Assist, dividends, and buybacks. | Jul 15–22 | Active (as of archive) | Open |
NVO Novo Nordisk A/S Healthcare | Defensive healthcare momentum with recent catalysts: stock rose about 14.9% over 21 trading days and is near the 21-day high. Positive evidence includes raised 2026 guidance, a share repurchase program, positive CHMP opinions for Wegovy 7.2 mg and Wegovy pill, plus UAE launch and UK approval for the pill. | Jul 15–22 | Active (as of archive) | Open |
NRIX Nurix Therapeutics, Inc. Healthcare | Speculative but catalyst-rich biotech setup: Roche collaboration brought $700M upfront and up to $2.3B in potential payments, while NX-5948 Phase 1a/b data showed 92.9% ORR in second-line post-BTK CLL/SLL patients. Shares are up about 38% over the last 20 trading days, supported by a stronger biotech tape. | Jul 15–22 | Active (as of archive) | Open |
Trust layer
Outcome log
Closed ideas with realised P/L. Winners and losers stay visible.
| Ticker | Window | Outcome | Closed | Link |
|---|---|---|---|---|
NRIX Nurix Therapeutics, Inc. Healthcare | Jul 7–14 | -5.8% | 2026-07-14 | Open |
VERA Vera Therapeutics, Inc. Healthcare | Jul 7–14 | +0.4% | 2026-07-14 | Open |
AORT Artivion, Inc. Healthcare | Jul 7–14 | -5.4% | 2026-07-14 | Open |
LQDA Liquidia Corporation Healthcare | Jul 7–14 | -5.8% | 2026-07-14 | Open |
FTNT Fortinet, Inc. Technology | Jul 7–14 | +5.1% | 2026-07-14 | Open |
DDOG Datadog, Inc. Technology | Jul 7–14 | +5.4% | 2026-07-14 | Open |
FROG JFrog Ltd. Technology | Jul 7–14 | -5.2% | 2026-07-14 | Open |
PSMT PriceSmart, Inc. Consumer Defensive | Jul 7–14 | +1.4% | 2026-07-14 | Open |
WDFC WD-40 Company Basic Materials | Jul 7–14 | -0.2% | 2026-07-14 | Open |
EVTC EVERTEC, Inc. Technology | Jul 7–14 | +1.6% | 2026-07-14 | Open |
Weekly rating moves
Rating moves
Upgrades and downgrades captured for the week.
Snapshot — week of 2026-07-15
- NVDA8.5NVIDIA Corporation · Technology
- ANET8.3Arista Networks, Inc. · Technology
- RMD8.0ResMed Inc. · Healthcare
- RELY8.0Remitly Global, Inc. · Technology
- SE8.0Sea Limited · Consumer Cyclical
- TOST8.0Toast, Inc. · Technology
- FICO8.0Fair Isaac Corporation · Technology
- V8.0Visa Inc. · Financial Services
- STX8.0Seagate Technology Holdings plc · Technology
- RY8.0Royal Bank of Canada · Financial Services
Quant Lab
Quant strategy tests
One concrete backtest at a time — strategy, universe, period, metric, limitation.
Quant Lab
Latest quant strategy test
Weekly-Daily Trend Alignment Momentum for US Large-Cap Stocks
MULTI_TIMEFRAME_TREND_MOMENTUMmomentummulti-timeframetrend-followingweekly-daily-alignment2018-01-01..2023-01-01
- Sharpe
- 0.70
- Total return
- +30.8%
- Max drawdown
- -11.9%
- Volatility
- +8.8%
Weekly-Daily Trend Alignment Momentum for US Large-Cap Stocks — strategy card Spec ID: spec-multitimeframe-momentum-us-stocks-1783167355 · Generated: 2026-07-04 12:32 UTC Cluster: Momentum · Sub Cluster: Weekly-Daily…
Latest run — Jul 4, 2026. Research artifact, not live performance.
Recently added
- Hybrid Overnight Momentum with Intraday Extension FadeSharpe 0.86·+38.1%
- Breadth-Aware Sector-Neutral Quality Momentum Long/Short Top 500 US StocksSharpe 0.71·+28.4%
- Regime-Adaptive Relative Momentum on Top 100 Most Traded U.S. StocksSharpe 1.08·+46.4%